Everything You Need to Know About Niemann-Pick for Step 1

Niemann-Pick disease is a high-yield lysosomal storage disorder (LSD) that USMLE loves to test via enzyme deficiency → lipid accumulation → classic organ findings (hepatosplenomegaly + neurodegeneration). This post covers what you need for Step 1 (and a bit of Step 2): definition, pathophysiology, presentation, diagnosis, treatment, and “can’t-miss” associations, with First Aid–style cross-references.

---

Where Niemann-Pick Fits (Biochem Framework)

Big picture: Lysosomal storage diseases

• LSDs are caused by defective lysosomal enzymes → accumulation of substrates in tissues
• Often present with:
  • Hepatosplenomegaly
  • Neurodegeneration (especially with sphingolipidoses)
  • Developmental delay/regression
  • Foamy macrophages due to lipid-laden lysosomes

Niemann-Pick (core classification)

Niemann-Pick is classically tested as:

• Type A and Type B: acid sphingomyelinase deficiency (aka ASM, gene SMPD1) → sphingomyelin accumulation
• Type C (separate mechanism): defect in cholesterol trafficking (genes NPC1/NPC2) → cholesterol accumulation (and other lipids)

---

Definition (What to memorize)

Niemann-Pick Types A/B (classic Step 1)

• Autosomal recessive
• Acid sphingomyelinase deficiency
• Accumulation: sphingomyelin in:
  • macrophages (→ “foamy” cells)
  • liver/spleen (→ hepatosplenomegaly)
  • brain (Type A >> Type B)

First Aid cross-reference (conceptual): Lysosomal storage diseases → Niemann-Pick listed under sphingolipidoses with sphingomyelinase deficiency, foamy cells, hepatosplenomegaly, neurodegeneration, cherry-red macula.

Niemann-Pick Type C (also tested)

• Autosomal recessive
• Defect: impaired intracellular cholesterol trafficking (NPC1/NPC2)
• Leads to cholesterol accumulation (and glycosphingolipids)
• Key clinical clue: vertical supranuclear gaze palsy (trouble with vertical eye movements)

---

Pathophysiology (How it causes the symptoms)

Types A/B: Acid sphingomyelinase deficiency

Normal role: acid sphingomyelinase breaks down sphingomyelin → ceramide + phosphorylcholine (in lysosomes)

Defect → accumulation of sphingomyelin:

• Reticuloendothelial system (RES) overload → hepatosplenomegaly
• Bone marrow infiltration → foamy macrophages; may contribute to cytopenias
• CNS involvement:
  • Type A: severe neurodegeneration (infantile)
  • Type B: minimal/no neurodegeneration (more visceral disease)

Type C: Cholesterol trafficking defect

• Impaired movement of cholesterol out of lysosomes/endosomes → cellular lipid overload
• Neurons (esp. cerebellar) affected → ataxia, cognitive decline
• Eye movement control affected → vertical gaze palsy

---

Clinical Presentation (Step 1 “buzzwords”)

Niemann-Pick Type A (infantile, severe neuro)

Classic vignette:

• Infant with progressive neurodegeneration
• Hepatosplenomegaly
• Failure to thrive
• ± cherry-red spot on macula
• Often fatal in early childhood

High-yield: Cherry-red macula can appear in both Tay-Sachs and Niemann-Pick (Type A classically). Differentiate by hepatosplenomegaly (present in Niemann-Pick, absent in Tay-Sachs).

Niemann-Pick Type B (chronic visceral)

• Later onset (childhood/adolescence)
• Hepatosplenomegaly
• Often pulmonary involvement (interstitial lung disease)
• Little to no neurodegeneration (key distinction from Type A)

Niemann-Pick Type C (school-age to adult; neuro + eye movement)

• Ataxia
• Dysarthria
• Cognitive decline
• Vertical supranuclear gaze palsy
• Hepatosplenomegaly may be present (often earlier in life)

---

Pathology & Histology (What they like to show)

“Foamy macrophages”

• Lipid-laden macrophages in RES organs
• Looks like vacuolated/foamy cytoplasm due to stored lipid

“Cherry-red macula”

• Retinal pallor from storage material in surrounding retina
• Fovea appears “cherry-red” because it is relatively spared (thin ganglion cell layer)

---

Diagnosis (What tests confirm it?)

Types A/B (acid sphingomyelinase deficiency)

Confirmatory testing:

• Low acid sphingomyelinase activity (e.g., in leukocytes or cultured fibroblasts)
• Genetic testing for SMPD1 mutations (increasingly common confirmation)

Supportive findings:

• Hepatosplenomegaly on exam/imaging
• ± Foam cells on bone marrow aspirate
• Labs may show dyslipidemia (esp. Type B), cytopenias if hypersplenism

Type C (cholesterol trafficking)

• Genetic testing: NPC1/NPC2
• Specialized cellular assays (historically filipin staining) may be referenced, but on USMLE the emphasis is usually clinical pattern + genetics

---

Treatment (What can you do?)

Types A/B

• Supportive care (nutrition, respiratory support, managing complications)
• Type B: disease-specific therapies are evolving; some settings use enzyme replacement approaches (exam questions typically keep it broad: supportive + specialist management)
• Transplant/experimental therapies may appear as “under investigation”

Type C

• Supportive management (neurologic, nutritional)
• Disease-modifying therapies may be mentioned in some resources, but for USMLE focus on recognition and mechanism rather than drug minutiae unless your course emphasizes it.

Step exam tip: If asked “treatment,” safest high-yield phrasing:

• Supportive care and genetic counseling
• Then add: “Targeted therapies exist for select subtypes but are evolving.”

---

High-Yield Differentials (Common traps)

Niemann-Pick vs Tay-Sachs (favorite comparison)

Both can have cherry-red macula and neurodegeneration, but:

Niemann-Pick vs Gaucher

• Gaucher: glucocerebrosidase deficiency, crumpled tissue paper macrophages, bone crises/Erlenmeyer flask deformity
• Niemann-Pick: foamy macrophages, cherry-red macula (type A), hepatosplenomegaly

---

HY Associations & Exam Clues (Memorize these)

Niemann-Pick Types A/B (ASM deficiency)

• Autosomal recessive
• Acid sphingomyelinase deficiency
• Sphingomyelin accumulation
• Foamy macrophages
• Hepatosplenomegaly
• Neurodegeneration: Type A yes, Type B minimal
• Cherry-red macula: classically Type A

Niemann-Pick Type C (cholesterol trafficking)

• NPC1/NPC2
• Cholesterol accumulation
• Vertical supranuclear gaze palsy
• Ataxia, cognitive decline ± hepatosplenomegaly

---

First Aid–Style Cross-References (Study-map links)

Use these as anchors while you flip through First Aid/your notes:

• Biochemistry → Lysosomal storage diseases (sphingolipidoses)
  • Niemann-Pick: sphingomyelinase deficiency, foamy cells, hepatosplenomegaly, neurodegeneration, cherry-red macula
• Biochemistry → Sphingolipid metabolism
  • Link enzyme defects (e.g., HexA vs sphingomyelinase) to clinical clues (HSM present vs absent)
• Pathology/Neuro → Cherry-red spot differentials
  • Tay-Sachs and Niemann-Pick are the classic pairing

---

Rapid Review (Last-minute cram)

• Niemann-Pick A/B: AR, acid sphingomyelinase ↓ (SMPD1) → sphingomyelin ↑ → foamy macrophages, hepatosplenomegaly; Type A neuro + cherry-red, Type B mostly visceral
• Niemann-Pick C: AR, NPC1/NPC2 cholesterol trafficking defect → cholesterol ↑, vertical gaze palsy, neuro decline ± HSM
• Cherry-red macula + hepatosplenomegaly → think Niemann-Pick (not Tay-Sachs)